A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

Over my forty years or so in and around dealing rooms and financial markets, I have heard many theories as to how to approach that problem and have settled on a process that has worked for me.

Centre for Astrophysics and Planetary Science, School of Physics and Astronomy, University of Kent, Canterbury CT2 7NH, United Kingdom ...